Table 1 DAAs after renal transplantation
Number of case | Sex Male/female | Platelets count, ×103/mm3, median (range) | CNI | HCV genotype | DAA regimen | Rate of SVR12 | Reference |
|---|---|---|---|---|---|---|---|
35 | 15:10 | 160 (180–290) | Tac:9 CyA:1 | 1a: 4 1b:15 2: 2 3:1 4:3 | SOF/LDV:9 SOF/SMV:6 SOF/DCV:4 SOF/RBV:3 SOF:LDV/RBV:1 SOF/SMV/RBV:1 PEG-IFN/RBV/SOF:1 | 35/35 | [13] |
20 | 16:4 | 180 (59–284) | Tac:19 CyA:1 | 1:4 1a:6 1a/1b:1 1b:6 2b:2 2a/2c:1 | SOF/LDV:7 SOF/SMV:9 SOF/DCV:1 SOF/RBV:3 | 20/20 | [14] |
4 | 2:1 | 201 (158–269) | Tac:3 | 4:3 | SOF/RBV:3 | 3/3 | [15] |